Article
Nanoparticulate RNA delivery systems in cancer
30 Jul 2020
Abstract excerpt
BACKGROUND: Drug delivery system is a common practice in cancer treatment. RNA interference-mediated post-transcriptional gene silencing holds promise as an approach to knockdown in the expression of target genes responsible for cancer cell growth and metastasis. RNA interference (RNAi) can be achieved by delivering small interfering RNA (siRNA) and short hairpin RNA (shRNA) to target cells. Since neither...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
